Background: Bacterial resistance to antibiotics is becoming a serious problem worldwide. The discovery of new and effective antimicrobials and/or resistance modulators is necessary to tackle the spread of resistance or to reverse the multi-drug resistance. We investigated the antibacterial and antibiotic-resistance modifying activities of the methanol extracts from Allanblackia gabonensis, Gladiolus quartinianus and Combretum molle against 29 Gram-negative bacteria including multi-drug resistant (MDR) phenotypes.
Background
Infectious diseases caused by multi-drug resistant (MDR) Gram-negative bacteria are worldwide health concern, causing increasingly morbidity and mortality particularly in developing countries [1] . In Cameroon, previous studies showed high levels of resistance to commonly used antibiotics in Gram-negative bacilli [2] . Several reports also mentioned an increase in the hospital dissemination of bacterial strains specifically those expressing drug efflux mechanism [3, 4] . Against Gram-negative bacteria, the discovery of efflux pump inhibitors (EPIs) is an attractive strategy to combat MDR phenotypes [5] . EPI generally interact with specific efflux pump proteins to restore the susceptibility of MDR bacteria to antibiotics [6] . Medicinal plants constitute an important source of chemotherapeutic molecules, in regards to the chemical diversity found in several species [7, 8] . In recent years, some plants have been successfully evaluated for their direct antibacterial action, and for their antibiotic-modulation activity [9] [10] [11] [12] . In the present work, we hypothesized that herbal medicines traditionally used for the treatment of infectious diseases could contain molecules acting as antibacterial and/ or antibiotic-resistance modulators. This study was therefore designed to investigate the in vitro antibacterial and antibiotic-resistance modifying activities of the methanol extracts from Allanblackia gabonensis Pellegr. (Clusiaceae), Gladiolus quartinianus A. Rich (Iridaceae) and Combretum molle R. Br. ex G. Don (Combretaceae) against Gramnegative bacteria including multi-drug phenotypes. These plants are traditionally used to manage various ailments including bacterial related infections.
Methods

Plant materials and extraction
Medicinal plants used in this work were collected in different areas of Cameroon between January and April 2012. The plants were identified at the National Herbarium (Yaoundé, Cameroon), where voucher specimens were deposited under the reference numbers ( Table 1) . The air-dried and powdered plant material was weighed (300 g) and soaked in 1 L of methanol (MeOH) for 48 h at room temperature. The filtrate obtained through Whatman filter paper No. 1 was concentrated under reduced pressure in vacuum to obtain the crude extracts. All crude extracts were then kept at 4°C until further uses.
Chemicals for antibacterial assays
Eight commonly used antibiotics including tetracycline (TET), kanamycin (KAN), streptomycin (STR), ciprofloxacin (CIP), norfloxacin (NOR), chloramphenicol (CHL), ampicillin (AMP), erythromycin (ERY) (Sigma-Aldrich, St Quentin Fallavier, France) were used. The p-Iodonitrotetrazolium chloride 0.2 % (INT) and phenylalanine arginine β-naphthylamide (PAβN) (Sigma-Aldrich) were used as bacterial growth indicator and efflux pumps inhibitor respectively.
Microorganisms and growth conditions
Pathogenic bacteria used in the study were Gram-negative bacteria including MDR isolates (Laboratory collection) and reference strains (American Type Culture Collection) of Escherichia coli (ATCC8739, ATCC10536, AG100, AG100A, AG100A Tet , AG102, MC4100 W3110), Enterobacter aerogenes (ATCC13048, CM64, EA27, EA3, EA289, EA298, EA294), Klebsiella pneumoniae (ATCC11296, KP55, KP63, K24, K2), Enterobacter cloacae (ECCI69, BM47, BM67), Pseudomonas aeruginosa (PA01, PA124) and Providencia stuartii (ATCC29916, NEA16, PS2636, PS299645) were used. Their features were previously reported [37] . They were maintained at 4°C and sub-cultured on a fresh appropriate Mueller Hinton Agar (MHA) for 24 h before any antibacterial test.
Preliminary phytochemical investigation
The plant extracts were screened for the presence of major secondary metabolite classes such as alkaloids, anthocyanins, anthraquinones, flavonoids, phenols, saponins, sterols and triterpenes according to common phytochemical methods previously described [38] . The tests were based on visual observation of the change in color or formation of precipitate after the addition of specific reagents.
Antibacterial assays
MICs and MBCs of the plant extracts and chloramphenicol were determined by microdilution method using rapid INT colorimetric assay [25, 39] . Briefly, the samples were first dissolved in 10 % Dimethyl-sulfoxide (DMSO)/Mueller Hinton Broth (MHB). The solution obtained was then added to MHB and serially diluted two fold (in a 96-well microplate). One hundred microliters of inoculum (1.5× 10 6 CFU/mL) prepared in MHB were then added. The plates were covered with a sterile plate sealer and then agitated with a shaker to mix the contents of the wells and incubated at 37°C for 18 h. The final concentration of DMSO was less than 2.5 %, and did not affect the microbial growth. Wells containing MHB, 100 μL of inoculum, and DMSO at a final concentration of 2.5 % served as the negative control. The MIC of each sample was detected after 18 h of incubation at 37°C following addition of 40 μL INT (0.2 mg/mL) and incubation at 37°C for 30 min. Viable bacteria reduced the yellow dye to a pink. The MIC was defined as the lowest sample concentration that prevented this change and that resulted in the complete inhibition of bacterial growth. The MBC of the sample was determined by sub-culturing 50 μL of the suspensions from the wells which did not show any growth after incubation during MIC assays to 150 μl of fresh broth, and re-incubated at 37°C for 48 h before revelation. The MBC was defined as the lowest concentration of sample which completely inhibited the growth of bacteria [40] . Each assay was performed in three independent tests in triplicate. The samples were also tested in the presence of phenylalanine arginine β-naphthylamide (PAβN) at a final concentration of 20 μg/mL as previously described [41] on nine MDR bacteria. All assays were performed three time in duplicate.
Antibiotic-modulation assay
To evaluate the antibiotic resistance modifying activity of the extracts, the MIC of antibiotic was determined in the presence or absence of the plant extracts. The 96-wells plate modulation method, as described by Stavri et al. [42] was used. Briefly, after serial dilutions of antibiotics (256-0.5 μg/mL), the plant extracts at their subinhibitory concentrations (MIC/2 and MIC/4; selected [19] ; hookworm, snake bite, leprosy, dysentery, general body swellings, arthritic and other inflammatory conditions, sterility, constipation [20, 21] ; Parasitic, protozoan, infectious diseases [22] , malaria [23] University of Dschang, West region of Cameroon; (6°30′N 10°30′E/6.500°N 10.500°E)
Mollic acid glucoside [21] ); β-D-glucopyranosyl 2α,3β,6β-trihydroxy-23-galloylolean-12-en-28-oate,combregenin, arjungenin, arjunglucoside I, and combreglucoside [24] .
Crude extracts were evaluated for: antibacterial activity [25] [26] [27] ; antimycobacterial [28] ; antifungal effects [29] ; antimalarial [30] ; anthelmintic activities [31] ; anti-HIV by inhibition of ribonuclease-H [19] ; Cytotoxic effects against T-24 bladder cancer cells [32] ; Anti-inflammatory activity [24] ; in vitro anticholinesterase and inhibitory effects on Rabbit Breathing [33] . Compounds: mollic acid glucoside (MAG) showed analgesic, anti-inflammatory properties in mice and rats [21] , cardiovascular effect [34] ; hypoglycaemic effect [35] ; Punicalgin and CM-A, two isolated tannins were assessed for their anti-HIV activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) [36] .
a Plants were identified at the Cameroon National Herbarium (HNC) after preliminary study; Table 2 ), were added and inoculation was done. The MIC was determined as described above. Modulation factors (MF), calculated as MIC Antibiotic alone /MIC Antibiotic alone + Extract ; was used to express the modulating or synergy effects of the plant extracts.
Results
Phytochemical Screening of the plant extracts
The main classes of secondary metabolites for each extract were screened and the results are summarized in Table 3 . Tannins, flavonoids, alkaloids and phenols were present in all tested extracts. Others classes of botanicals were selectively distributed in different plant extracts.
Antibacterial activity of the plant extracts
The results summarized in Table 4 (1) 16 (2) 32 (2) 16 (1) 32 (1) 128 (1) MIC/4 64 (1) - (NA) 128 (1) 16 (2) 64 (1) 16 (1) 32 (1) 128 (1) MIC/8 64 (1) - (NA) 128 (1) 128 (1) 64 (1) 16 (1) 32 (1) 128 (1) MIC/16 64 (1) - (NA) 128 (1) 128 (1) 64 (1) 16 (1) 32 (1) 128 (1) AGB MIC/2 64(1) -(NA) 128 (1) 128 (1) 32 (2) 8 (2) 32 (1) 128 (1) MIC/4 64(1) -(NA) 128 (1) 128 (1) 64 (1) 16 (1) 32 (1) 128 (1) MIC/8 64 (1) - (NA) 128 (1) 128 (1) 64 (1) 16 (1) 32 (1) CML mostly showed moderate activity with MIC values ranging from 128-512 μg/mL. The activity of CHL was comparable to that of plant extracts in certain cases. This was the case with AGF, AGFl and AGR against K. pneumoniae Kp55 (64 μg/mL); AGF against K. pneumoniae Kp53 (64 μg/mL), and AGFl against P. stuartii PS2636 (32 μg/mL). MICs values equal or above 1024 μg/mL were obtained with the extract from G. quartinianus (GQW). MBCs values were generally equal or below 1024 μg/mL (Table 4) .
Antibacterial activity of the extracts in the presence of an Efflux Pumps Inhibitors
In the present work, extracts were combined with PAβN; However, no significant increase of the activities of the tested plant extracts was generally observed. Only AGL showed 4 times decrease of MICs against E. coli AG102 and E. cloacae BM67. In contrast, PAβN significantly improved the activity of the reference drug, CHL (more than 16 times) on MDR bacteria used (Table 5) . Tables 2, 6 and 7 highlights the potentiating effects of the extracts on the activity of eight commonly used antibiotics. The most important modulating effects were observed of association CML with aminoglycosides (kanamycin and streptomycin), the potentiation effects varying from 77.78 to 88.89 % and from 66.67 to 77.78 % at MIC/2 and MIC/4 respectively; and with tetracycline (100 % and 77.78 % at MIC/2 and MIC/4 respectively) ( Table 6 ). The modulating effects also ranged between 50 to 67 %, with the extract from A. gabonensis fruits (AGF) when combined at (MIC/2) with the some antibiotics. At MIC/4, AGF showed synergy less than 50 % on the tested bacteria with all antibiotics (Table 7) . The most significant increases of antibiotic activity in the presence of plant extracts were noted with the association of streptomycin and CML and AGF on E. coli AG100A Tet, with more than 128 fold and 64-fold decreases of MIC respectively. No increase of activity was noted with ampicillin, a β-lactamine when it was combined with plant extracts.
Antibiotic resistance modifying activities of the plant extracts
Discussion
Medicinal plants are potential source of antimicrobial agents used in the treatment of infectious diseases [43, 44] . According to Kuete et al. [45, 46] , the antibacterial activity of a plant extract is considered significant when the MICs are below 100 μg/mL, moderate when 100 ≤ MIC ≤ 625 μg/mL and weak when MIC are above 625 μg/mL. Consequently, the antibacterial activities of the tested extracts particularly those from A. gabonensis (AGF, AGR, AGB and AGFl) and C. molle (CML) were generally moderated (Table 4 ). Significant activities were recorded with AGF, AGR, AGB, and AGFl respectively on 37.93 %, 24.14 %, 20.70 % and 17.24 %. This highlights the good antibacterial potential of the tested extracts. The overall activity recorded with most of the studied extracts could be considered significant, especially those from A. gabonensis and C. molle [47] . When analyzing carefully the MIC and MBC results for the extract, it can be noted that MBC ≤ 4 were obtained with these samples on most of the tested bacterial species, suggesting their killing effects [48] .
PAβN is a potent inhibitor of RND systems like AcrAB-TolC in Enterobacteriaceae or MexAB-OprM in P. aeruginosa used in the present work [49, 50] ; The activity observed when chloramphenicol was tested in the presence of PAβN increased significantly, confirming that the tested bacteria are good models of efflux pumpsexpressing bacteria.
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--: MIC and MBC not detected at up to 1024 μg/mL, Values in bold represent significant antibacterial activity of the plant extract (2) 32 (2) 256 (1) 64 (2) 8 ( 8) 64 (1) 16 (4) 32 (2) 66.65
MIC/4 8 (1) 32 (1) 64 (1) 256 (1) 64 (2) 32 (2) 64 (1) 32 (2) 32 (2) (2) 64 (1) 128 (1) 1 (1) 64 (2) 1 (1) 16 (2) 33.33
MIC/4 ≤0.5(NA) ≤0.5 64 (2) 64 (1) 128 (1) 1 (1) 64 (2) 1 (1) 16 (2) Percentage of antibiotic's modulation activity by the Plant extracts; Indications in bold represent the modulation factor ≥ 2 and antibiotics having a percentage of modulating effect greather than 50 %; NA: Not applicable bacteria [9-11, 37, 51-54] . Herein, we demonstrated that a beneficial effect of the combination of the extracts from the leaves of C. molle (CML) and fruits of A. gabonensis (AGF) with CHL, KAN and STR could be achieved. Synergistic or modulating effects of the plant extracts particularly C. molle extract with antibiotics were noted on more than 70 % of the tested MDR bacteria, suggesting that some of their constituents can act as efflux pump inhibitors [51] . These constituents might act by blocking the efflux pumps located in the cell membrane in the tested bacteria, preventing the extrusion of antibiotics in the cytoplasm and therefore restoring their activity as observed in this study [55, 56] . This is the first time to report the potential of the studied extracts, particularly those from the leaves of C. molle (CML) and the fruits of A. gabonensis (AGF) to reverse antibiotic resistance in MDR bacteria.
Conclusion
This study provides informative data on the antimicrobial potential of the tested plant extracts and suggests that extracts from Allanblackia gabonensis could be a source of natural antibacterial products whilst Combretum molle leaves extract could contain both antibacterial substances and antibiotic-modulation agents. These data indicate that these plants can be used to fight bacterial infections and especially those involving MDR phenotypes.
